Streetbeat News

Stock Prices

BLK

GBTC

Cryptocurrency markets have started the week in green, with notable gains in Bitcoin, Solana, and Dogecoin. Ethereum spot ETFs are anticipated to impact the market. Bitcoin's short liquidations peaked, and Wisconsin revealed owning Bitcoin through BlackRock and Grayscale ETFs.

Portfolio Pulse from Khyathi Dalal

June 03, 2024 | 8:20 pm

INGN

Inogen, Inc. (NASDAQ:INGN) published a study in the journal Pulmonary Therapy showing that portable oxygen concentrators (POCs) are associated with increased survival and cost-effectiveness compared to other long-term oxygen therapies. The study, using data from the French national healthcare system, analyzed over 244,000 patients and found that POCs improved survival rates and had similar healthcare resource use compared to stationary concentrators, compressed tanks, and liquid oxygen.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:20 pm

HSDT

Helius Medical Technologies has regained compliance with Nasdaq listing requirements following a financing event on May 9. The company now satisfies all criteria for continued listing on the Nasdaq Capital Market.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:20 pm

HQY

HealthEquity shares are trading higher after the company reported better-than-expected Q1 financial results and issued FY25 EPS guidance above estimates. Additionally, the company provided FY25 revenue guidance with its midpoint above estimates.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:17 pm

TSM

Wealthy investors have taken a bullish stance on Taiwan Semiconductor (NYSE:TSM), with significant options activity indicating a price target range of $80 to $220. The stock is currently trading at $155.61, up by 3.03%. Analysts have a consensus target price of $168.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 8:15 pm

FDX

Recent options activity for FedEx (NYSE:FDX) shows a bullish stance among large investors, with 64% of trades being bullish. The price target for these options ranges from $235 to $330. FedEx's stock is currently down by 2.1% at $248.62, with an RSI indicating it may be approaching oversold territory. Analysts have set a consensus target price of $314.5, with ratings from JP Morgan (Neutral, $296) and UBS (Buy, $333).

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 8:15 pm

BLND

Blend Labs, Inc. (BLND) will join the Russell 2000 Index on July 1, 2024, as part of the annual reconstitution.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:15 pm

MYGN

Myriad Genetics' Patient-Outcomes Study validating RiskScore as a clinical breast cancer risk assessment tool has been published in Medical Genetics and Genomics.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:13 pm

GTLB

GitLab has raised its fiscal year 2025 revenue outlook from $725M-$731M to $733M-$737M, and adjusted EPS from $0.19-$0.23 to $0.34-$0.37. This update comes after completing the fiscal year 2025 SSP allocation analysis, which resulted in a $4 million headwind to revenue guidance. Despite this, the company has increased its guidance due to first-quarter top-line outperformance.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:12 pm

FGEN

REGN

FibroGen shares are trading higher after the company announced that the FDA cleared its Investigational New Drug FG-3165. Additionally, FibroGen has entered into a clinical trial supply agreement with Regeneron Pharmaceuticals to evaluate FG-3165 and FG-3175 in combination with LIBTAYO.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:10 pm